Search

everythinglearnresearchcommunity

for

Search:↓

Scalp abscesses can occur after hair loss treatments and may be caused by Mycobacterium abscessus.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Various medications and vaccines can cause serious side effects.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

WS Biotin, a new form of D-Biotin, improves water solubility and shows potential for hair and skin care without being toxic at low levels.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Analog 23 is a promising compound for prostate cancer treatment.

The topical solution improved hair density and appearance in men with androgenetic alopecia.

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

N-acetylcysteine may help treat trichotillomania.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Caffeine and DMG increase calcium influx in hair follicle cells without being toxic.

CCN1 may aid wound healing, but more research with larger samples is needed.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib helps with early hair regrowth in people with alopecia areata.